• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2010 - 2019年香港2型糖尿病患者临床参数趋势及糖尿病并发症发生率:一项回顾性队列研究

Trends of clinical parameters and incidences of diabetes mellitus complications among patients with type 2 diabetes mellitus in Hong Kong, 2010-2019: a retrospective cohort study.

作者信息

Wang Yuan, Xu Wanchun, Mak Ivy Lynn, Chin Weng Yee, Yu Esther Yee Tak, Lam Cindy Lo Kuen, Wan Eric Yuk Fai

机构信息

Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

Department of Family Medicine, The University of Hong Kong - Shenzhen Hospital, Guangdong, China.

出版信息

EClinicalMedicine. 2023 May 11;60:101999. doi: 10.1016/j.eclinm.2023.101999. eCollection 2023 Jun.

DOI:10.1016/j.eclinm.2023.101999
PMID:37234549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10206435/
Abstract

BACKGROUND

Diabetes mellitus-related characteristics, including available medications, onset ages, and newly-introduced management program, have been changing recently in Hong Kong, especially after the introduction of the Risk Assessment and Management Program-Diabetes Mellitus in all outpatient clinics in 2009. To understand the plural change and improve the management of patients with Type 2 Diabetes Mellitus (T2DM) based on the latest data, we examined the trends of clinical parameters, T2DM complications and mortality in patients with T2DM in Hong Kong from 2010 to 2019.

METHODS

In this retrospective cohort study, we acquired data from the Clinical Management System of the Hospital Authority in Hong Kong. Among adults with T2DM diagnosed on or before Sept 30, 2010, and with at least one attendance in general outpatient clinics between Aug 1, 2009, to Sept 30, 2010, we investigated the age-standardised trends of clinical parameters including haemoglobin A1c, systolic blood pressure, diastolic blood pressure, low-density lipoprotein cholesterol (LDL-C), body mass index and estimated glomerular filtration rate (eGFR), complications including cardiovascular disease (CVD), peripheral vascular disease (PVD), sight-threatening diabetic retinopathy (STDR), neuropathy, eGFR<45 mL/min/1.73 m and end-stage renal disease (ESRD), and all-cause mortality from 2010 to 2019 and tested the statistical significance of the trends using generalised estimating equation by sex, level of clinical parameters and age groups.

FINDINGS

In total, 82,650 males and 97,734 females with T2DM were identified. LDL-C decreased from 3 to 2 mmol/L in both males and females, while other clinical parameters changed within 5% over the full decade from 2010 to 2019. CVD, PVD, STDR, and neuropathy had declining incidences, while ESRD and all-cause mortality had increasing incidences from 2010 to 2019. The incidence of eGFR<45 mL/min/1.73 m increased in males but decreased in females. The odds ratio (OR) of ESRD (1.13, 95% CI [1.12, 1.15]) was highest in both males and females while the ORs of STDR (0.94, 95% CI [0.92, 0.96]) and neuropathy (0.90, 95% CI [0.88, 0.92]) were lowest in males and females, respectively. Complications and all-cause mortality trends varied among baseline HbA1c, eGFR, and age subgroups. In contrast to the findings in other age groups, the incidence of any outcomes did not decrease in younger patients (<45 years) from 2010 to 2019.

INTERPRETATION

Improvements were observed in LDL-C and incidences of most complications from 2010 to 2019. Worse performance in the younger age group and increasing incidence of renal complications and mortality need more attention in managing patients with T2DM.

FUNDING

The Health and Medical Research Fund, the Health Bureau, and Government of the Hong Kong Special Administrative Region.

摘要

背景

与糖尿病相关的特征,包括可用药物、发病年龄和新推出的管理方案,近年来在香港一直在变化,特别是在2009年所有门诊诊所引入糖尿病风险评估与管理方案之后。为了基于最新数据了解这些多元变化并改善2型糖尿病(T2DM)患者的管理,我们研究了2010年至2019年香港T2DM患者的临床参数、T2DM并发症及死亡率的趋势。

方法

在这项回顾性队列研究中,我们从香港医院管理局的临床管理系统获取数据。在2010年9月30日及以前诊断为T2DM,且在2009年8月1日至2010年9月30日期间至少在普通门诊就诊一次的成年人中,我们调查了临床参数(包括糖化血红蛋白、收缩压、舒张压、低密度脂蛋白胆固醇(LDL-C)、体重指数和估算肾小球滤过率(eGFR))、并发症(包括心血管疾病(CVD)、外周血管疾病(PVD)、威胁视力的糖尿病视网膜病变(STDR)、神经病变、eGFR<45 mL/min/1.73 m²和终末期肾病(ESRD))以及2010年至2019年全因死亡率的年龄标准化趋势,并使用广义估计方程按性别、临床参数水平和年龄组检验趋势的统计学意义。

结果

共识别出82,650例男性和97,734例女性T2DM患者。男性和女性的LDL-C均从3 mmol/L降至2 mmol/L,而其他临床参数在2010年至2019年的整个十年间变化幅度在5%以内。2010年至2019年,CVD、PVD、STDR和神经病变的发病率下降,而ESRD和全因死亡率的发病率上升。男性中eGFR<45 mL/min/1.73 m²的发病率上升,女性中则下降。ESRD的优势比(OR)(1.13,95%置信区间[1.12, 1.15])在男性和女性中均最高,而STDR(0.94,95%置信区间[0.92, 0.96])和神经病变(0.90,95%置信区间[0.88, 0.92])的OR在男性和女性中分别最低。并发症和全因死亡率趋势在基线糖化血红蛋白、eGFR和年龄亚组中有所不同。与其他年龄组的结果相反,2010年至2019年年轻患者(<45岁)中任何结局的发病率均未下降。

解读

2010年至2019年期间,LDL-C及大多数并发症的发病率有所改善。年轻年龄组的较差表现以及肾脏并发症和死亡率的上升在T2DM患者管理中需要更多关注。

资助

香港特别行政区政府卫生署健康及医学研究基金。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b545/10206435/8b8ffa5f0dea/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b545/10206435/d82304ca6f5b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b545/10206435/0a447eaf965d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b545/10206435/8b8ffa5f0dea/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b545/10206435/d82304ca6f5b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b545/10206435/0a447eaf965d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b545/10206435/8b8ffa5f0dea/gr3.jpg

相似文献

1
Trends of clinical parameters and incidences of diabetes mellitus complications among patients with type 2 diabetes mellitus in Hong Kong, 2010-2019: a retrospective cohort study.2010 - 2019年香港2型糖尿病患者临床参数趋势及糖尿病并发症发生率:一项回顾性队列研究
EClinicalMedicine. 2023 May 11;60:101999. doi: 10.1016/j.eclinm.2023.101999. eCollection 2023 Jun.
2
Diabetes with poor-control HbA1c is cardiovascular disease 'risk equivalent' for mortality: UK Biobank and Hong Kong population-based cohort study.HbA1c 控制不佳的糖尿病与心血管疾病死亡率相当:英国生物库和香港基于人群的队列研究。
BMJ Open Diabetes Res Care. 2023 Jan;11(1). doi: 10.1136/bmjdrc-2022-003075.
3
Declining Trends of Cardiovascular-Renal Complications and Mortality in Type 2 Diabetes: The Hong Kong Diabetes Database.2 型糖尿病心血管-肾脏并发症及死亡率的下降趋势:香港糖尿病数据库。
Diabetes Care. 2017 Jul;40(7):928-935. doi: 10.2337/dc16-2354. Epub 2017 May 10.
4
Microalbuminuria as the Tip of Iceberg in Type 2 Diabetes Mellitus: Prevalence, Risk Factors, and Associated Diabetic Complications.微量白蛋白尿:2型糖尿病的冰山一角——患病率、危险因素及相关糖尿病并发症
Cureus. 2023 Aug 9;15(8):e43190. doi: 10.7759/cureus.43190. eCollection 2023 Aug.
5
Dose-response association of diabetic kidney disease with routine clinical parameters in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.2型糖尿病患者糖尿病肾病与常规临床参数的剂量反应关联:一项系统评价和荟萃分析
EClinicalMedicine. 2024 Feb 13;69:102482. doi: 10.1016/j.eclinm.2024.102482. eCollection 2024 Mar.
6
Clinical use of sodium-glucose co-transporter-2 inhibitors in Chinese patients with type 2 diabetes mellitus.钠-葡萄糖共转运蛋白 2 抑制剂在中国 2 型糖尿病患者中的临床应用。
Singapore Med J. 2019 Jun;60(6):309-313. doi: 10.11622/smedj.2018139. Epub 2018 Nov 7.
7
Clinical outcomes following discontinuation of metformin in patients with type 2 diabetes and advanced chronic kidney disease in Hong Kong: a territory-wide, retrospective cohort and target trial emulation study.香港2型糖尿病合并晚期慢性肾脏病患者停用二甲双胍后的临床结局:一项全港性的回顾性队列研究及目标试验模拟研究
EClinicalMedicine. 2024 Mar 28;71:102568. doi: 10.1016/j.eclinm.2024.102568. eCollection 2024 May.
8
End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry.香港2型糖尿病患者的终末期肾病风险方程:香港糖尿病登记处
Diabetologia. 2006 Oct;49(10):2299-308. doi: 10.1007/s00125-006-0376-3. Epub 2006 Aug 30.
9
Prevalence of diabetic nephropathy among Chinese patients with type 2 diabetes mellitus and different categories of their estimated glomerular filtration rate based on the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation in primary care in Hong Kong: a cross-sectional study.香港基层医疗中基于慢性肾脏病流行病学合作组织(CKD-EPI)方程的2型糖尿病中国患者糖尿病肾病患病率及其不同类别估算肾小球滤过率:一项横断面研究
J Diabetes Metab Disord. 2019 Nov 15;18(2):281-288. doi: 10.1007/s40200-018-00382-y. eCollection 2019 Dec.
10
Kidney Disease in Diabetes糖尿病肾病

引用本文的文献

1
Time Trends of Body Mass Index and its Impact on Glycemic Control Among Finnish Patients with Type 2 Diabetes.芬兰2型糖尿病患者体重指数的时间趋势及其对血糖控制的影响
Diabetes Ther. 2025 Jun 16. doi: 10.1007/s13300-025-01763-2.
2
Indirect effect of the COVID-19 pandemic on cardiovascular diseases incidence, mortality, and healthcare use among patients with hypertension but without SARS-CoV-2 infection in Hong Kong: an interrupted time series analysis.2019年冠状病毒病大流行对香港高血压但未感染严重急性呼吸综合征冠状病毒2患者心血管疾病发病率、死亡率及医疗服务利用的间接影响:一项中断时间序列分析
Hypertens Res. 2025 May 23. doi: 10.1038/s41440-025-02230-y.
3

本文引用的文献

1
Trends in the Incidence of Hospitalization for Major Diabetes-Related Complications in People With Type 1 and Type 2 Diabetes in Australia, 2010-2019.2010 - 2019年澳大利亚1型和2型糖尿病患者重大糖尿病相关并发症住院发生率的趋势
Diabetes Care. 2022 Apr 1;45(4):789-797. doi: 10.2337/dc21-2268.
2
Trends in cardiovascular risk factors and treatment goals in patients with diabetes in Singapore-analysis of the SingHealth Diabetes Registry.新加坡糖尿病患者心血管风险因素和治疗目标的趋势分析——基于 SingHealth 糖尿病注册研究。
PLoS One. 2021 Nov 8;16(11):e0259157. doi: 10.1371/journal.pone.0259157. eCollection 2021.
3
Clinical value of serum miR-214-3p expression in the diagnosis of type 2 diabetes mellitus and prediction of its chronic complications.
血清miR-214-3p表达在2型糖尿病诊断及慢性并发症预测中的临床价值
BMC Endocr Disord. 2025 Apr 14;25(1):98. doi: 10.1186/s12902-025-01916-1.
4
PRKD2 as a novel target for targeting the diabetes-osteoporosis nexus.PRKD2作为靶向糖尿病-骨质疏松症关联的新靶点。
Sci Rep. 2025 Feb 8;15(1):4703. doi: 10.1038/s41598-025-89235-2.
5
Expressions of glycemic parameters, lipid profile, and thyroid hormone in patients with type 2 diabetes mellitus and their correlation.2 型糖尿病患者血糖参数、血脂谱和甲状腺激素的表达及其相关性。
Immun Inflamm Dis. 2024 Jul;12(7):e1282. doi: 10.1002/iid3.1282.
6
Behind the Hospital Ward: In-Hospital Mortality of Type 2 Diabetes Mellitus Patients in Indonesia (Analysis of National Health Insurance Claim Sample Data).医院病房背后:印度尼西亚 2 型糖尿病患者的院内死亡率(国家健康保险索赔样本数据分析)。
Int J Environ Res Public Health. 2024 May 1;21(5):581. doi: 10.3390/ijerph21050581.
7
Temporal trends in chronic complications of diabetes by sex in community-based people with type 2 diabetes: the Fremantle Diabetes Study.基于社区的 2 型糖尿病患者中性别对糖尿病慢性并发症的时间趋势:弗里曼特尔糖尿病研究。
Cardiovasc Diabetol. 2023 Sep 16;22(1):253. doi: 10.1186/s12933-023-01980-8.
Trends in kidney failure and kidney replacement therapy in people with diabetes in Hong Kong, 2002-2015: A retrospective cohort study.
2002 - 2015年香港糖尿病患者肾衰竭及肾脏替代治疗趋势:一项回顾性队列研究
Lancet Reg Health West Pac. 2021 Jun 9;11:100165. doi: 10.1016/j.lanwpc.2021.100165. eCollection 2021 Jun.
4
Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records.2001 年至 2018 年英格兰有和无糖尿病患者主要死亡原因的趋势:基于关联初级保健记录的流行病学分析。
Lancet Diabetes Endocrinol. 2021 Mar;9(3):165-173. doi: 10.1016/S2213-8587(20)30431-9. Epub 2021 Feb 4.
5
Declining mortality in older people with type 2 diabetes masks rising excess risks at younger ages: a population-based study of all-cause and cause-specific mortality over 13 years.2 型糖尿病老年患者死亡率的下降掩盖了年轻患者超额风险的上升:一项基于人群的全因和死因特异性死亡率研究,随访时间为 13 年。
Int J Epidemiol. 2021 Aug 30;50(4):1362-1372. doi: 10.1093/ije/dyaa270.
6
Trends in Glucose-Lowering Drug Use, Glycemic Control, and Severe Hypoglycemia in Adults With Diabetes in Hong Kong, 2002-2016.2002 - 2016年香港糖尿病成年人降糖药物使用、血糖控制及严重低血糖的趋势
Diabetes Care. 2020 Dec;43(12):2967-2974. doi: 10.2337/dc20-0260. Epub 2020 Oct 12.
7
Trends in diabetes-related complications in Hong Kong, 2001-2016: a retrospective cohort study.2001-2016 年香港糖尿病相关并发症趋势:一项回顾性队列研究。
Cardiovasc Diabetol. 2020 May 12;19(1):60. doi: 10.1186/s12933-020-01039-y.
8
Young-onset type 2 diabetes mellitus - implications for morbidity and mortality.青年发病的2型糖尿病——对发病率和死亡率的影响
Nat Rev Endocrinol. 2020 Jun;16(6):321-331. doi: 10.1038/s41574-020-0334-z. Epub 2020 Mar 20.
9
Time-trend analysis of fruit and vegetable intake in Hong Kong, 2004-2016.2004-2016 年香港水果和蔬菜摄入量的时间趋势分析。
Public Health. 2019 Dec;177:102-111. doi: 10.1016/j.puhe.2019.08.012. Epub 2019 Sep 24.
10
Trends of mortality in diabetic patients in Taiwan: A nationwide survey in 2005-2014.台湾地区糖尿病患者死亡率趋势:2005-2014 年全国性调查。
J Formos Med Assoc. 2019 Nov;118 Suppl 2:S83-S89. doi: 10.1016/j.jfma.2019.07.008. Epub 2019 Jul 24.